nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Methotrexate—multiple sclerosis	0.0248	1	CbGbCtD
Penicillamine—Haemorrhage—Cladribine—multiple sclerosis	0.00348	0.00357	CcSEcCtD
Penicillamine—Pancreatitis—Azathioprine—multiple sclerosis	0.00347	0.00355	CcSEcCtD
Penicillamine—Urinary tract disorder—Cladribine—multiple sclerosis	0.00344	0.00352	CcSEcCtD
Penicillamine—Urethral disorder—Cladribine—multiple sclerosis	0.00341	0.0035	CcSEcCtD
Penicillamine—Bone marrow depression—Methotrexate—multiple sclerosis	0.00336	0.00345	CcSEcCtD
Penicillamine—Pancytopenia—Azathioprine—multiple sclerosis	0.00336	0.00344	CcSEcCtD
Penicillamine—Leukocytosis—Betamethasone—multiple sclerosis	0.00332	0.0034	CcSEcCtD
Penicillamine—Leukocytosis—Dexamethasone—multiple sclerosis	0.00332	0.0034	CcSEcCtD
Penicillamine—Neuropathy—Triamcinolone—multiple sclerosis	0.00323	0.00331	CcSEcCtD
Penicillamine—Neuropathy—Methylprednisolone—multiple sclerosis	0.00322	0.0033	CcSEcCtD
Penicillamine—Interstitial lung disease—Methotrexate—multiple sclerosis	0.00321	0.00329	CcSEcCtD
Penicillamine—Vasculitis—Dexamethasone—multiple sclerosis	0.0032	0.00328	CcSEcCtD
Penicillamine—Vasculitis—Betamethasone—multiple sclerosis	0.0032	0.00328	CcSEcCtD
Penicillamine—Angiopathy—Cladribine—multiple sclerosis	0.00316	0.00324	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.00313	0.00321	CcSEcCtD
Penicillamine—Alopecia—Cladribine—multiple sclerosis	0.00308	0.00315	CcSEcCtD
Penicillamine—Mental disorder—Cladribine—multiple sclerosis	0.00305	0.00313	CcSEcCtD
Penicillamine—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00302	0.0031	CcSEcCtD
Penicillamine—Diarrhoea—Fingolimod—multiple sclerosis	0.00298	0.00306	CcSEcCtD
Penicillamine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00298	0.00306	CcSEcCtD
Penicillamine—Injury—Prednisolone—multiple sclerosis	0.00295	0.00303	CcSEcCtD
Penicillamine—Agranulocytosis—Azathioprine—multiple sclerosis	0.00294	0.00302	CcSEcCtD
Penicillamine—Neuropathy—Betamethasone—multiple sclerosis	0.00293	0.003	CcSEcCtD
Penicillamine—Neuropathy—Dexamethasone—multiple sclerosis	0.00293	0.003	CcSEcCtD
Penicillamine—Leukocytosis—Prednisone—multiple sclerosis	0.00289	0.00296	CcSEcCtD
Penicillamine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.00288	0.00296	CcSEcCtD
Penicillamine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.00288	0.00295	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.00286	0.00293	CcSEcCtD
Penicillamine—Haemoglobin—Azathioprine—multiple sclerosis	0.00284	0.00292	CcSEcCtD
Penicillamine—Haemorrhage—Azathioprine—multiple sclerosis	0.00283	0.0029	CcSEcCtD
Penicillamine—Anaemia—Cladribine—multiple sclerosis	0.0028	0.00287	CcSEcCtD
Penicillamine—Vasculitis—Prednisone—multiple sclerosis	0.00278	0.00285	CcSEcCtD
Penicillamine—Injury—Triamcinolone—multiple sclerosis	0.00271	0.00278	CcSEcCtD
Penicillamine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00271	0.00278	CcSEcCtD
Penicillamine—Injury—Methylprednisolone—multiple sclerosis	0.00271	0.00278	CcSEcCtD
Penicillamine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00262	0.00268	CcSEcCtD
Penicillamine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00262	0.00268	CcSEcCtD
Penicillamine—Extravasation—Methotrexate—multiple sclerosis	0.0026	0.00267	CcSEcCtD
Penicillamine—Proteinuria—Methotrexate—multiple sclerosis	0.00258	0.00265	CcSEcCtD
Penicillamine—Arthralgia—Cladribine—multiple sclerosis	0.00258	0.00264	CcSEcCtD
Penicillamine—Anxiety—Cladribine—multiple sclerosis	0.00257	0.00264	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00256	0.00263	CcSEcCtD
Penicillamine—Neuropathy—Prednisone—multiple sclerosis	0.00255	0.00261	CcSEcCtD
Penicillamine—Protein urine present—Methotrexate—multiple sclerosis	0.00255	0.00261	CcSEcCtD
Penicillamine—Renal failure—Mitoxantrone—multiple sclerosis	0.00251	0.00257	CcSEcCtD
Penicillamine—Alopecia—Azathioprine—multiple sclerosis	0.0025	0.00256	CcSEcCtD
Penicillamine—Stomatitis—Mitoxantrone—multiple sclerosis	0.00248	0.00255	CcSEcCtD
Penicillamine—Glossitis—Methotrexate—multiple sclerosis	0.00246	0.00253	CcSEcCtD
Penicillamine—Injury—Dexamethasone—multiple sclerosis	0.00246	0.00253	CcSEcCtD
Penicillamine—Injury—Betamethasone—multiple sclerosis	0.00246	0.00253	CcSEcCtD
Penicillamine—Haematuria—Mitoxantrone—multiple sclerosis	0.00243	0.00249	CcSEcCtD
Penicillamine—Thrombocytopenia—Cladribine—multiple sclerosis	0.00242	0.00248	CcSEcCtD
Penicillamine—Skin disorder—Cladribine—multiple sclerosis	0.0024	0.00246	CcSEcCtD
Penicillamine—Muscular weakness—Prednisolone—multiple sclerosis	0.00239	0.00245	CcSEcCtD
Penicillamine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00238	0.00244	CcSEcCtD
Penicillamine—Anorexia—Cladribine—multiple sclerosis	0.00236	0.00242	CcSEcCtD
Penicillamine—Vasculitis—Methotrexate—multiple sclerosis	0.00233	0.00238	CcSEcCtD
Penicillamine—Haemoglobin—Mitoxantrone—multiple sclerosis	0.0023	0.00236	CcSEcCtD
Penicillamine—Pancreatitis—Prednisolone—multiple sclerosis	0.0023	0.00236	CcSEcCtD
Penicillamine—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00229	0.00235	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisone—multiple sclerosis	0.00228	0.00234	CcSEcCtD
Penicillamine—Anaemia—Azathioprine—multiple sclerosis	0.00228	0.00233	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00225	0.00231	CcSEcCtD
Penicillamine—Leukopenia—Azathioprine—multiple sclerosis	0.00221	0.00226	CcSEcCtD
Penicillamine—Muscular weakness—Triamcinolone—multiple sclerosis	0.0022	0.00226	CcSEcCtD
Penicillamine—Muscular weakness—Methylprednisolone—multiple sclerosis	0.0022	0.00225	CcSEcCtD
Penicillamine—Asthma—Triamcinolone—multiple sclerosis	0.00216	0.00221	CcSEcCtD
Penicillamine—Decreased appetite—Cladribine—multiple sclerosis	0.00215	0.0022	CcSEcCtD
Penicillamine—Injury—Prednisone—multiple sclerosis	0.00214	0.0022	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00213	0.00219	CcSEcCtD
Penicillamine—Pancreatitis—Triamcinolone—multiple sclerosis	0.00211	0.00217	CcSEcCtD
Penicillamine—Pancreatitis—Methylprednisolone—multiple sclerosis	0.00211	0.00216	CcSEcCtD
Penicillamine—Arthralgia—Azathioprine—multiple sclerosis	0.0021	0.00215	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00208	0.00214	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—multiple sclerosis	0.00205	0.0021	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00205	0.0021	CcSEcCtD
Penicillamine—Alopecia—Mitoxantrone—multiple sclerosis	0.00202	0.00207	CcSEcCtD
Penicillamine—Muscular weakness—Dexamethasone—multiple sclerosis	0.002	0.00205	CcSEcCtD
Penicillamine—Muscular weakness—Betamethasone—multiple sclerosis	0.002	0.00205	CcSEcCtD
Penicillamine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00197	0.00202	CcSEcCtD
Penicillamine—Urticaria—Cladribine—multiple sclerosis	0.00196	0.00201	CcSEcCtD
Penicillamine—Body temperature increased—Cladribine—multiple sclerosis	0.00195	0.002	CcSEcCtD
Penicillamine—Skin disorder—Azathioprine—multiple sclerosis	0.00195	0.002	CcSEcCtD
Penicillamine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00195	0.002	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—multiple sclerosis	0.00193	0.00198	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.0019	0.00195	CcSEcCtD
Penicillamine—Haemoglobin—Prednisolone—multiple sclerosis	0.00189	0.00193	CcSEcCtD
Penicillamine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00188	0.00193	CcSEcCtD
Penicillamine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00188	0.00193	CcSEcCtD
Penicillamine—Haemorrhage—Prednisolone—multiple sclerosis	0.00188	0.00192	CcSEcCtD
Penicillamine—Anaemia—Mitoxantrone—multiple sclerosis	0.00184	0.00189	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—multiple sclerosis	0.00183	0.00188	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00183	0.00188	CcSEcCtD
Penicillamine—Hypersensitivity—Cladribine—multiple sclerosis	0.00182	0.00187	CcSEcCtD
Penicillamine—Leukopenia—Mitoxantrone—multiple sclerosis	0.00178	0.00183	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00175	0.00179	CcSEcCtD
Penicillamine—Muscular weakness—Prednisone—multiple sclerosis	0.00174	0.00178	CcSEcCtD
Penicillamine—Haemoglobin—Triamcinolone—multiple sclerosis	0.00173	0.00178	CcSEcCtD
Penicillamine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00173	0.00177	CcSEcCtD
Penicillamine—Haemorrhage—Triamcinolone—multiple sclerosis	0.00173	0.00177	CcSEcCtD
Penicillamine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00172	0.00177	CcSEcCtD
Penicillamine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.00171	0.00175	CcSEcCtD
Penicillamine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.00171	0.00175	CcSEcCtD
Penicillamine—Arthralgia—Mitoxantrone—multiple sclerosis	0.0017	0.00174	CcSEcCtD
Penicillamine—Diarrhoea—Cladribine—multiple sclerosis	0.00169	0.00173	CcSEcCtD
Penicillamine—Anxiety—Mitoxantrone—multiple sclerosis	0.00169	0.00173	CcSEcCtD
Penicillamine—Pancreatitis—Prednisone—multiple sclerosis	0.00167	0.00171	CcSEcCtD
Penicillamine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00159	0.00163	CcSEcCtD
Penicillamine—Body temperature increased—Azathioprine—multiple sclerosis	0.00159	0.00163	CcSEcCtD
Penicillamine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00158	0.00162	CcSEcCtD
Penicillamine—Haemoglobin—Dexamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Penicillamine—Haemoglobin—Betamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Penicillamine—Vomiting—Cladribine—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Penicillamine—Haemorrhage—Betamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Penicillamine—Haemorrhage—Dexamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Penicillamine—Angiopathy—Methylprednisolone—multiple sclerosis	0.00156	0.0016	CcSEcCtD
Penicillamine—Rash—Cladribine—multiple sclerosis	0.00156	0.0016	CcSEcCtD
Penicillamine—Dermatitis—Cladribine—multiple sclerosis	0.00156	0.0016	CcSEcCtD
Penicillamine—Anorexia—Mitoxantrone—multiple sclerosis	0.00155	0.00159	CcSEcCtD
Penicillamine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00151	0.00155	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00149	0.00153	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00148	0.00152	CcSEcCtD
Penicillamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00148	0.00152	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00148	0.00152	CcSEcCtD
Penicillamine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00147	0.00151	CcSEcCtD
Penicillamine—Nausea—Cladribine—multiple sclerosis	0.00147	0.00151	CcSEcCtD
Penicillamine—Asthma—Methotrexate—multiple sclerosis	0.00142	0.00146	CcSEcCtD
Penicillamine—Angiopathy—Dexamethasone—multiple sclerosis	0.00142	0.00146	CcSEcCtD
Penicillamine—Angiopathy—Betamethasone—multiple sclerosis	0.00142	0.00146	CcSEcCtD
Penicillamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00141	0.00145	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—multiple sclerosis	0.00141	0.00145	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—multiple sclerosis	0.0014	0.00143	CcSEcCtD
Penicillamine—Alopecia—Betamethasone—multiple sclerosis	0.00138	0.00142	CcSEcCtD
Penicillamine—Alopecia—Dexamethasone—multiple sclerosis	0.00138	0.00142	CcSEcCtD
Penicillamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00138	0.00141	CcSEcCtD
Penicillamine—Haemoglobin—Prednisone—multiple sclerosis	0.00137	0.00141	CcSEcCtD
Penicillamine—Haemorrhage—Prednisone—multiple sclerosis	0.00136	0.0014	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—multiple sclerosis	0.00135	0.00139	CcSEcCtD
Penicillamine—Urticaria—Mitoxantrone—multiple sclerosis	0.00129	0.00132	CcSEcCtD
Penicillamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00128	0.00132	CcSEcCtD
Penicillamine—Vomiting—Azathioprine—multiple sclerosis	0.00128	0.00131	CcSEcCtD
Penicillamine—Arthralgia—Methylprednisolone—multiple sclerosis	0.00128	0.00131	CcSEcCtD
Penicillamine—Anxiety—Methylprednisolone—multiple sclerosis	0.00127	0.0013	CcSEcCtD
Penicillamine—Rash—Azathioprine—multiple sclerosis	0.00127	0.0013	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00127	0.0013	CcSEcCtD
Penicillamine—Dermatitis—Azathioprine—multiple sclerosis	0.00127	0.0013	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—multiple sclerosis	0.00125	0.00128	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—multiple sclerosis	0.00124	0.00127	CcSEcCtD
Penicillamine—Angiopathy—Prednisone—multiple sclerosis	0.00124	0.00127	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—multiple sclerosis	0.00121	0.00124	CcSEcCtD
Penicillamine—Alopecia—Prednisone—multiple sclerosis	0.00121	0.00124	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.0012	0.00123	CcSEcCtD
Penicillamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.0012	0.00123	CcSEcCtD
Penicillamine—Mental disorder—Prednisone—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Penicillamine—Nausea—Azathioprine—multiple sclerosis	0.00119	0.00122	CcSEcCtD
Penicillamine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00119	0.00122	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—multiple sclerosis	0.00118	0.00121	CcSEcCtD
Penicillamine—Anxiety—Betamethasone—multiple sclerosis	0.00116	0.00119	CcSEcCtD
Penicillamine—Anxiety—Dexamethasone—multiple sclerosis	0.00116	0.00119	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—multiple sclerosis	0.00115	0.00117	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00113	0.00115	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—multiple sclerosis	0.00112	0.00115	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00112	0.00115	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00111	0.00114	CcSEcCtD
Penicillamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00111	0.00114	CcSEcCtD
Penicillamine—Anaemia—Prednisone—multiple sclerosis	0.0011	0.00113	CcSEcCtD
Penicillamine—Agitation—Prednisone—multiple sclerosis	0.00109	0.00112	CcSEcCtD
Penicillamine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00109	0.00112	CcSEcCtD
Penicillamine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00109	0.00112	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Penicillamine—Anorexia—Dexamethasone—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Penicillamine—Anorexia—Betamethasone—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Penicillamine—Urticaria—Prednisolone—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Penicillamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Penicillamine—Rash—Mitoxantrone—multiple sclerosis	0.00102	0.00105	CcSEcCtD
Penicillamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00102	0.00105	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Penicillamine—Arthralgia—Prednisone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Penicillamine—Anxiety—Prednisone—multiple sclerosis	0.00101	0.00103	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—multiple sclerosis	0.00101	0.00103	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.001	0.00103	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—multiple sclerosis	0.000999	0.00102	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000982	0.00101	CcSEcCtD
Penicillamine—Urticaria—Triamcinolone—multiple sclerosis	0.000974	0.000999	CcSEcCtD
Penicillamine—Urticaria—Methylprednisolone—multiple sclerosis	0.000972	0.000997	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—multiple sclerosis	0.000972	0.000996	CcSEcCtD
Penicillamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000969	0.000994	CcSEcCtD
Penicillamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000967	0.000992	CcSEcCtD
Penicillamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000967	0.000992	CcSEcCtD
Penicillamine—Nausea—Mitoxantrone—multiple sclerosis	0.000965	0.00099	CcSEcCtD
Penicillamine—Skin disorder—Prednisone—multiple sclerosis	0.000941	0.000965	CcSEcCtD
Penicillamine—Anorexia—Prednisone—multiple sclerosis	0.000924	0.000947	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—multiple sclerosis	0.000917	0.00094	CcSEcCtD
Penicillamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000903	0.000926	CcSEcCtD
Penicillamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000901	0.000924	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—multiple sclerosis	0.000888	0.000911	CcSEcCtD
Penicillamine—Urticaria—Betamethasone—multiple sclerosis	0.000884	0.000906	CcSEcCtD
Penicillamine—Urticaria—Dexamethasone—multiple sclerosis	0.000884	0.000906	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000883	0.000905	CcSEcCtD
Penicillamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00088	0.000902	CcSEcCtD
Penicillamine—Body temperature increased—Betamethasone—multiple sclerosis	0.00088	0.000902	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—multiple sclerosis	0.000845	0.000866	CcSEcCtD
Penicillamine—Decreased appetite—Prednisone—multiple sclerosis	0.000842	0.000864	CcSEcCtD
Penicillamine—Rash—Prednisolone—multiple sclerosis	0.000841	0.000862	CcSEcCtD
Penicillamine—Dermatitis—Prednisolone—multiple sclerosis	0.00084	0.000861	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000839	0.00086	CcSEcCtD
Penicillamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000837	0.000858	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000793	0.000813	CcSEcCtD
Penicillamine—Nausea—Prednisolone—multiple sclerosis	0.000792	0.000812	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—multiple sclerosis	0.000787	0.000807	CcSEcCtD
Penicillamine—Vomiting—Triamcinolone—multiple sclerosis	0.00078	0.000799	CcSEcCtD
Penicillamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000778	0.000798	CcSEcCtD
Penicillamine—Rash—Triamcinolone—multiple sclerosis	0.000773	0.000793	CcSEcCtD
Penicillamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000772	0.000792	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—multiple sclerosis	0.000772	0.000791	CcSEcCtD
Penicillamine—Rash—Methylprednisolone—multiple sclerosis	0.000771	0.000791	CcSEcCtD
Penicillamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000771	0.00079	CcSEcCtD
Penicillamine—Urticaria—Prednisone—multiple sclerosis	0.00077	0.000789	CcSEcCtD
Penicillamine—Body temperature increased—Prednisone—multiple sclerosis	0.000766	0.000785	CcSEcCtD
Penicillamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000761	0.000781	CcSEcCtD
Penicillamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000761	0.000781	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000738	0.000757	CcSEcCtD
Penicillamine—Nausea—Triamcinolone—multiple sclerosis	0.000728	0.000747	CcSEcCtD
Penicillamine—Nausea—Methylprednisolone—multiple sclerosis	0.000727	0.000745	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000714	0.000732	CcSEcCtD
Penicillamine—Vomiting—Dexamethasone—multiple sclerosis	0.000707	0.000725	CcSEcCtD
Penicillamine—Vomiting—Betamethasone—multiple sclerosis	0.000707	0.000725	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000704	0.000722	CcSEcCtD
Penicillamine—Rash—Dexamethasone—multiple sclerosis	0.000702	0.000719	CcSEcCtD
Penicillamine—Rash—Betamethasone—multiple sclerosis	0.000702	0.000719	CcSEcCtD
Penicillamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000701	0.000719	CcSEcCtD
Penicillamine—Dermatitis—Betamethasone—multiple sclerosis	0.000701	0.000719	CcSEcCtD
Penicillamine—Diarrhoea—Prednisone—multiple sclerosis	0.000663	0.00068	CcSEcCtD
Penicillamine—Nausea—Dexamethasone—multiple sclerosis	0.000661	0.000678	CcSEcCtD
Penicillamine—Nausea—Betamethasone—multiple sclerosis	0.000661	0.000678	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—multiple sclerosis	0.000643	0.00066	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—multiple sclerosis	0.00064	0.000656	CcSEcCtD
Penicillamine—Vomiting—Prednisone—multiple sclerosis	0.000616	0.000632	CcSEcCtD
Penicillamine—Rash—Prednisone—multiple sclerosis	0.000611	0.000626	CcSEcCtD
Penicillamine—Dermatitis—Prednisone—multiple sclerosis	0.00061	0.000626	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000597	0.000612	CcSEcCtD
Penicillamine—Nausea—Prednisone—multiple sclerosis	0.000576	0.00059	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000554	0.000568	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—multiple sclerosis	0.000515	0.000528	CcSEcCtD
Penicillamine—Rash—Methotrexate—multiple sclerosis	0.000511	0.000524	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—multiple sclerosis	0.00051	0.000523	CcSEcCtD
Penicillamine—Nausea—Methotrexate—multiple sclerosis	0.000481	0.000493	CcSEcCtD
